ABBY LINK: Open Payments
NPI 1821415233 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 76 payments from 21 companies in 2025. Trend: 2023 $1,412 · 2024 $906 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $259 |
| PFIZER INC. | 13 | $183 |
| ABBVIE INC. | 8 | $180 |
| GlaxoSmithKline, LLC. | 10 | $143 |
| Esperion Therapeutics, Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| HEARTFLOW, INC. | 2 | $53 |
| Amgen Inc. | 3 | $52 |
Products named: FARXIGA, NURTEC ODT, ELIQUIS, TRELEGY ELLIPTA, NEXLETOL, VRAYLAR, AIRSUPRA, JARDIANCE.
Industry payments across MO — which companies pay providers there.
